chr9-35674301-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001216.3(CA9):āc.342T>Cā(p.Pro114Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000188 in 1,614,150 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.00035 ( 0 hom., cov: 31)
Exomes š: 0.00017 ( 2 hom. )
Consequence
CA9
NM_001216.3 synonymous
NM_001216.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.73
Genes affected
CA9 (HGNC:1383): (carbonic anhydrase 9) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12. [provided by RefSeq, Jun 2014]
ARHGEF39 (HGNC:25909): (Rho guanine nucleotide exchange factor 39) Predicted to enable guanyl-nucleotide exchange factor activity. Involved in positive regulation of cell migration. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 9-35674301-T-C is Benign according to our data. Variant chr9-35674301-T-C is described in ClinVar as [Benign]. Clinvar id is 739805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.73 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA9 | NM_001216.3 | c.342T>C | p.Pro114Pro | synonymous_variant | 1/11 | ENST00000378357.9 | NP_001207.2 | |
CA9 | XM_047423849.1 | c.342T>C | p.Pro114Pro | synonymous_variant | 1/6 | XP_047279805.1 | ||
CA9 | XM_047423850.1 | c.342T>C | p.Pro114Pro | synonymous_variant | 1/6 | XP_047279806.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA9 | ENST00000378357.9 | c.342T>C | p.Pro114Pro | synonymous_variant | 1/11 | 1 | NM_001216.3 | ENSP00000367608.4 | ||
ARHGEF39 | ENST00000490638.5 | n.-586A>G | non_coding_transcript_exon_variant | 1/12 | 1 | ENSP00000436756.1 | ||||
ARHGEF39 | ENST00000490638.5 | n.-586A>G | 5_prime_UTR_variant | 1/12 | 1 | ENSP00000436756.1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152184Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
55
AN:
152184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000776 AC: 195AN: 251176Hom.: 0 AF XY: 0.000545 AC XY: 74AN XY: 135828
GnomAD3 exomes
AF:
AC:
195
AN:
251176
Hom.:
AF XY:
AC XY:
74
AN XY:
135828
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000171 AC: 250AN: 1461848Hom.: 2 Cov.: 33 AF XY: 0.000147 AC XY: 107AN XY: 727226
GnomAD4 exome
AF:
AC:
250
AN:
1461848
Hom.:
Cov.:
33
AF XY:
AC XY:
107
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000355 AC: 54AN: 152302Hom.: 0 Cov.: 31 AF XY: 0.000349 AC XY: 26AN XY: 74446
GnomAD4 genome
AF:
AC:
54
AN:
152302
Hom.:
Cov.:
31
AF XY:
AC XY:
26
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at